Tag: Oncolytics Biotech

Industry

ONCY’s Market Quandary: Decoding the Ups and Downs of 2023

The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. This year’s metric has recorded a Price decrease

CROX
Stock

ONCY’s Stock Market Pendulum: Swinging Between Gains and Losses

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a loss of -51.32%.However, over the last six months, we can see a stronger performance of -49.57%. Over

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.